Innovators Club

ClotProtect Therapeutics is developing a next-generation treatment for uncontrollable blood loss by directly targeting plasmin, the enzyme responsible for breaking down blood clots, offering a potentially more effective alternative to the current standard of treatment. Led by Professor Helen Philippou, the startup has secured early funding and is progressing towards clinical trials, with the goal of developing both intravenous and intramuscular formulations for use in emergency healthcare settings.

Shubhi Raghav

February 27, 2025

The chemical industry is a major contributor to global carbon emissions, relying heavily on fossil fuels and energy-intensive processes. Deep Blue BioTech addresses this by using genetically engineered cyanobacteria to produce sustainable, biodegradable chemicals from CO2, light, and water. Their innovative approach aims to reduce the industry's carbon footprint while promoting green alternatives in sectors such as cosmetics and pharmaceuticals.

Omar Ajaz

February 10, 2025

With the high failure rates of novel oncology drugs and the urgent need for better preclinical testing, MOMO Biotech is tackling one of the toughest challenges in cancer research. Their innovative TMEmic device accurately mimics the tumour microenvironment, enabling better drug testing, while their integrated hardware and AI-powered software solution supports biotech companies in accelerating clinical advancements.

Bill Carton

February 1, 2025

In a healthcare landscape where women’s health is often under-researched and underserved, there is a pressing need for innovative companies to address gaps in access to personalized, convenient, and reliable diagnostic tools. EVE is developing a medical device in the women’s health space - a non-invasive, home-based testing kit capable of analysing biomarkers found in menstrual blood. Their technology offers women a convenient and proactive way to monitor their health.

Lucy Ahern

February 7, 2025

London, September 2022 - The Innovators Club, a network accelerator programme run by non-profit Science Entrepreneur Club (SEC), has today announced its third cohort welcoming six startups innovating in the field of synthetic biology (SynBio).

Aonghus Topham

December 13, 2024